Cyclacel Pharmaceuticals Files 8-K with Bylaw Amendments
Ticker: BGMSP · Form: 8-K · Filed: May 7, 2025 · CIK: 1130166
| Field | Detail |
|---|---|
| Company | Cyclacel Pharmaceuticals, INC. (BGMSP) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financial-reporting
Related Tickers: CYCC
TL;DR
Cyclacel filed an 8-K on 5/7/25 for bylaw changes & financial docs. No major financial news yet.
AI Summary
Cyclacel Pharmaceuticals, Inc. filed an 8-K on May 7, 2025, reporting amendments to its articles of incorporation or bylaws, a Regulation FD disclosure, and financial statements/exhibits. The company, formerly Xcyte Therapies Inc., is incorporated in Delaware and has its fiscal year end on December 31st. The filing does not contain specific financial figures or details about the nature of the amendments or disclosures.
Why It Matters
This filing indicates potential changes in the company's governance or financial reporting structure, which could impact its operational framework and investor relations.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose significant negative or positive financial events.
Key Players & Entities
- Cyclacel Pharmaceuticals, Inc. (company) — Registrant
- XCYTE THERAPIES INC (company) — Former Company Name
- May 7, 2025 (date) — Date of Report
FAQ
What specific amendments were made to Cyclacel Pharmaceuticals' articles of incorporation or bylaws?
The filing does not specify the exact nature of the amendments to the articles of incorporation or bylaws, only that they were reported.
What is the purpose of the Regulation FD disclosure mentioned in the filing?
The filing lists 'Regulation FD Disclosure' as an item information but does not provide details on the content of the disclosure.
Are there any significant financial statements or exhibits included with this 8-K filing?
The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content or financial figures are not detailed in the provided text.
When was Cyclacel Pharmaceuticals, Inc. previously known as?
Cyclacel Pharmaceuticals, Inc. was formerly known as XCYTE THERAPIES INC, with a date of name change on December 18, 2000.
What is the state of incorporation and fiscal year end for Cyclacel Pharmaceuticals, Inc.?
Cyclacel Pharmaceuticals, Inc. is incorporated in Delaware and its fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Cyclacel Pharmaceuticals, Inc. (BGMSP).